The absolute bioavailability of an oral sustained-release formulation of desvenlafaxine succinate in healthy subjects.

被引：4

作者：

Parker, VD ^{[1
]}

Richards, LS ^{[1
]}

Nichols, AI ^{[1
]}

Behrle, JA ^{[1
]}

Fruncillo, RJ ^{[1
]}

机构：

[1] Wyeth Res, Collegeville, PA USA

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 2005年 / 77卷 / 02期

关键词：

D O I：

10.1016/j.clpt.2004.12.071

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：P47 / P47

页数：1

共 50 条

[1] An ascending multiple-dose study of the safety and pharmacokinetics of a sustained-release formulation of desvenlafaxine succinate in healthy subjects
Richards, LS
Behrle, JA
Nichols, AI
Fruncillo, RJ
Paul, J
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P84 - P84
[2] An open-label, randomized, crossover study of the relative bioavailability of desvenlafaxine after oral administration of extended-release venlafaxine and sustained-release desvenlafaxine succinate in healthy subjects
Nichols, AI
Patat, A
Baird-Bellaire, S
Behrle, JA
Chretien, P
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P86 - P86
[3] Safety, pharmacokinetics (ZCASEPK) and pharmacodynamics (PD) of ascending single oral doses of sustained-release desvenlafaxine succinate (DVS-SR) in healthy subjects.
Patat, A
Behrle, JA
Troy, SM
Decours, JH
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P44 - P44
[4] BIOAVAILABILITY OF AMFEPRAMONE HYDROCHLORIDE SUSTAINED-RELEASE PELLETS FORMULATION IN HEALTHY-SUBJECTS
DANGOR, CM
BECKETT, AH
VELTMAN, AM
ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1987, 37-1 (06): : 736 - 739
[5] An open-label, randomized single-dose, dose-proportionality study of oral doses of a sustained-release formulation of desvenlafaxine succinate in healthy subjects
Behrle, JA
Nichols, AI
McGrory, SB
Raible, D
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P82 - P82
[6] Absolute oral bioavailability and bioequivalence of telbivudine in healthy subjects.
Zhou, X.
Constance, B. A. Fielman
Kleber, K.
Frank, D.
Ke, J.
Chao, C. C.
Brown, N. A.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S74 - S74
[7] Absolute bioavailability of vildagliptin in healthy subjects.
He, YL
Sabo, R
Balez, S
Wang, Y
Campestrini, J
Marion, A
Ligueros-Saylan, M
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (02) : P38 - P38
[8] ABSOLUTE BIOAVAILABILITY OF A SPECIAL ACETYLSALICYLIC-ACID SUSTAINED-RELEASE FORMULATION
LUCKER, PW
SWOBODA, M
WETZELSBERGER, N
ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1989, 39-1 (03): : 391 - 394
[9] BIOAVAILABILITY OF A SUSTAINED-RELEASE DYPHYLLINE FORMULATION
SIMONS, KJ
SIMONS, FER
BIERMAN, CW
JOURNAL OF CLINICAL PHARMACOLOGY, 1977, 17 (04): : 237 - 242
[10] Bioavailability of a generic sustained-release formulation of diclofenac compared with the standard sustained-release formulation
Hooper, IT
Allen, E
McLaughlin, K
Ward, C
Sioufi, A
CLINICAL DRUG INVESTIGATION, 1996, 12 (05) : 259 - 270

← 1 2 3 4 5 →